Medicinal plant activity on Helicobacter pylori related diseases

More than 50%of the world population is infected with Helicobacter pylori(H.pylori).The bacterium highly links to peptic ulcer diseases and duodenal ulcer,which was classified as a groupⅠcarcinogen in 1994 by the WHO.The pathogenesis of H.pylori is contributed by its virulence factors including urea...

Full description

Saved in:
Bibliographic Details
Published inWorld journal of gastroenterology : WJG Vol. 20; no. 30; pp. 10368 - 10382
Main Author Wang, Yuan-Chuen
Format Journal Article
LanguageEnglish
Published United States Baishideng Publishing Group Inc 14.08.2014
Subjects
Animals
Anti-Bacterial Agents - therapeutic use
Anti-Inflammatory Agents - therapeutic use
factor
Gastritis - diagnosis
Gastritis - drug therapy
Gastritis - microbiology
Helicobacter
Helicobacter Infections - complications
Helicobacter Infections - diagnosis
Helicobacter Infections - drug therapy
Helicobacter Infections - microbiology
Helicobacter pylori - drug effects
Helicobacter pylori - genetics
Helicobacter pylori - metabolism
Helicobacter pylori - pathogenicity
Humans
Medicinal
Phytotherapy
pla
Plant Preparations - therapeutic use
Plants, Medicinal
pylori
Topic Highlight
Treatment Outcome
Virulence
Virulence Factors - genetics
Virulence Factors - metabolism
Nuclear factor-κB pathway
Helicobacter pylori
Virulence factor
Active compound
Inflammation
Gastric cancer
Mechanism
Medicinal plant
Online AccessGet full text

Cover

Abstract More than 50%of the world population is infected with Helicobacter pylori(H.pylori).The bacterium highly links to peptic ulcer diseases and duodenal ulcer,which was classified as a groupⅠcarcinogen in 1994 by the WHO.The pathogenesis of H.pylori is contributed by its virulence factors including urease,flagella,vacuolating cytotoxin A(VacA),cytotoxin-associated gene antigen(Cag A),and others.Of those virulence factors,VacA and CagA play the key roles.Infection with H.pylori vacA-positive strains can lead to vacuolation and apoptosis,whereas infection with cagA-positive strains might result in severe gastric inflammation and gastric cancer.Numerous medicinal plants have been reported for their anti-H.pylori activity,and the relevant active compounds including polyphenols,flavonoids,quinones,coumarins,terpenoids,and alkaloids have been studied.The anti-H.pylori action mechanisms,including inhibition of enzymatic(urease,DNA gyrase,dihydrofolate reductase,N-acetyltransferase,and myeloperoxidase)and adhesive activities,high redox potential,and hydrophilic/hydrophobic natures of compounds,have also been discussed in detail.H.pylori-induced gastric inflammation may progress to superficial gastritis,atrophic gastritis,and finally gastric cancer.Many natural products have anti-H.pylori-induced inflammation activity and the relevant mechanisms include suppression of nuclear factor-κB and mitogen-activated protein kinase pathway activation and inhibition of oxidative stress.Anti-H.pylori induced gastric inflammatory effects of plant products,including quercetin,apigenin,carotenoids-rich algae,tea product,garlic extract,apple peel polyphenol,and finger-root extract,have been documented.In conclusion,many medicinal plant products possess anti-H.pylori activity as well as an anti-H.pylori-induced gastric inflammatory effect.Those plant products have showed great potential as pharmaceutical candidates for H.pylori eradication and H.pylori induced related gastric disease prevention.
AbstractList More than 50%of the world population is infected with Helicobacter pylori(H.pylori).The bacterium highly links to peptic ulcer diseases and duodenal ulcer,which was classified as a groupⅠcarcinogen in 1994 by the WHO.The pathogenesis of H.pylori is contributed by its virulence factors including urease,flagella,vacuolating cytotoxin A(VacA),cytotoxin-associated gene antigen(Cag A),and others.Of those virulence factors,VacA and CagA play the key roles.Infection with H.pylori vacA-positive strains can lead to vacuolation and apoptosis,whereas infection with cagA-positive strains might result in severe gastric inflammation and gastric cancer.Numerous medicinal plants have been reported for their anti-H.pylori activity,and the relevant active compounds including polyphenols,flavonoids,quinones,coumarins,terpenoids,and alkaloids have been studied.The anti-H.pylori action mechanisms,including inhibition of enzymatic(urease,DNA gyrase,dihydrofolate reductase,N-acetyltransferase,and myeloperoxidase)and adhesive activities,high redox potential,and hydrophilic/hydrophobic natures of compounds,have also been discussed in detail.H.pylori-induced gastric inflammation may progress to superficial gastritis,atrophic gastritis,and finally gastric cancer.Many natural products have anti-H.pylori-induced inflammation activity and the relevant mechanisms include suppression of nuclear factor-κB and mitogen-activated protein kinase pathway activation and inhibition of oxidative stress.Anti-H.pylori induced gastric inflammatory effects of plant products,including quercetin,apigenin,carotenoids-rich algae,tea product,garlic extract,apple peel polyphenol,and finger-root extract,have been documented.In conclusion,many medicinal plant products possess anti-H.pylori activity as well as an anti-H.pylori-induced gastric inflammatory effect.Those plant products have showed great potential as pharmaceutical candidates for H.pylori eradication and H.pylori induced related gastric disease prevention.
More than 50% of the world population is infected with Helicobacter pylori ( H. pylori ). The bacterium highly links to peptic ulcer diseases and duodenal ulcer, which was classified as a group I carcinogen in 1994 by the WHO. The pathogenesis of H. pylori is contributed by its virulence factors including urease, flagella, vacuolating cytotoxin A (VacA), cytotoxin-associated gene antigen (Cag A), and others. Of those virulence factors, VacA and CagA play the key roles. Infection with H. pylori vacA -positive strains can lead to vacuolation and apoptosis, whereas infection with cagA-positive strains might result in severe gastric inflammation and gastric cancer. Numerous medicinal plants have been reported for their anti- H. pylori activity, and the relevant active compounds including polyphenols, flavonoids, quinones, coumarins, terpenoids, and alkaloids have been studied. The anti- H. pylori action mechanisms, including inhibition of enzymatic (urease, DNA gyrase, dihydrofolate reductase, N -acetyltransferase, and myeloperoxidase) and adhesive activities, high redox potential, and hydrophilic/hydrophobic natures of compounds, have also been discussed in detail. H. pylori -induced gastric inflammation may progress to superficial gastritis, atrophic gastritis, and finally gastric cancer. Many natural products have anti- H. pylori -induced inflammation activity and the relevant mechanisms include suppression of nuclear factor-κB and mitogen-activated protein kinase pathway activation and inhibition of oxidative stress. Anti- H. pylori induced gastric inflammatory effects of plant products, including quercetin, apigenin, carotenoids-rich algae, tea product, garlic extract, apple peel polyphenol, and finger-root extract, have been documented. In conclusion, many medicinal plant products possess anti- H. pylori activity as well as an anti- H. pylori -induced gastric inflammatory effect. Those plant products have showed great potential as pharmaceutical candidates for H. pylori eradication and H. pylori induced related gastric disease prevention.
More than 50% of the world population is infected with Helicobacter pylori (H. pylori). The bacterium highly links to peptic ulcer diseases and duodenal ulcer, which was classified as a group I carcinogen in 1994 by the WHO. The pathogenesis of H. pylori is contributed by its virulence factors including urease, flagella, vacuolating cytotoxin A (VacA), cytotoxin-associated gene antigen (Cag A), and others. Of those virulence factors, VacA and CagA play the key roles. Infection with H. pylori vacA-positive strains can lead to vacuolation and apoptosis, whereas infection with cagA-positive strains might result in severe gastric inflammation and gastric cancer. Numerous medicinal plants have been reported for their anti-H. pylori activity, and the relevant active compounds including polyphenols, flavonoids, quinones, coumarins, terpenoids, and alkaloids have been studied. The anti-H. pylori action mechanisms, including inhibition of enzymatic (urease, DNA gyrase, dihydrofolate reductase, N-acetyltransferase, and myeloperoxidase) and adhesive activities, high redox potential, and hydrophilic/hydrophobic natures of compounds, have also been discussed in detail. H. pylori-induced gastric inflammation may progress to superficial gastritis, atrophic gastritis, and finally gastric cancer. Many natural products have anti-H. pylori-induced inflammation activity and the relevant mechanisms include suppression of nuclear factor-κB and mitogen-activated protein kinase pathway activation and inhibition of oxidative stress. Anti-H. pylori induced gastric inflammatory effects of plant products, including quercetin, apigenin, carotenoids-rich algae, tea product, garlic extract, apple peel polyphenol, and finger-root extract, have been documented. In conclusion, many medicinal plant products possess anti-H. pylori activity as well as an anti-H. pylori-induced gastric inflammatory effect. Those plant products have showed great potential as pharmaceutical candidates for H. pylori eradication and H. pylori induced related gastric disease prevention.More than 50% of the world population is infected with Helicobacter pylori (H. pylori). The bacterium highly links to peptic ulcer diseases and duodenal ulcer, which was classified as a group I carcinogen in 1994 by the WHO. The pathogenesis of H. pylori is contributed by its virulence factors including urease, flagella, vacuolating cytotoxin A (VacA), cytotoxin-associated gene antigen (Cag A), and others. Of those virulence factors, VacA and CagA play the key roles. Infection with H. pylori vacA-positive strains can lead to vacuolation and apoptosis, whereas infection with cagA-positive strains might result in severe gastric inflammation and gastric cancer. Numerous medicinal plants have been reported for their anti-H. pylori activity, and the relevant active compounds including polyphenols, flavonoids, quinones, coumarins, terpenoids, and alkaloids have been studied. The anti-H. pylori action mechanisms, including inhibition of enzymatic (urease, DNA gyrase, dihydrofolate reductase, N-acetyltransferase, and myeloperoxidase) and adhesive activities, high redox potential, and hydrophilic/hydrophobic natures of compounds, have also been discussed in detail. H. pylori-induced gastric inflammation may progress to superficial gastritis, atrophic gastritis, and finally gastric cancer. Many natural products have anti-H. pylori-induced inflammation activity and the relevant mechanisms include suppression of nuclear factor-κB and mitogen-activated protein kinase pathway activation and inhibition of oxidative stress. Anti-H. pylori induced gastric inflammatory effects of plant products, including quercetin, apigenin, carotenoids-rich algae, tea product, garlic extract, apple peel polyphenol, and finger-root extract, have been documented. In conclusion, many medicinal plant products possess anti-H. pylori activity as well as an anti-H. pylori-induced gastric inflammatory effect. Those plant products have showed great potential as pharmaceutical candidates for H. pylori eradication and H. pylori induced related gastric disease prevention.
More than 50% of the world population is infected with Helicobacter pylori (H. pylori). The bacterium highly links to peptic ulcer diseases and duodenal ulcer, which was classified as a group I carcinogen in 1994 by the WHO. The pathogenesis of H. pylori is contributed by its virulence factors including urease, flagella, vacuolating cytotoxin A (VacA), cytotoxin-associated gene antigen (Cag A), and others. Of those virulence factors, VacA and CagA play the key roles. Infection with H. pylori vacA-positive strains can lead to vacuolation and apoptosis, whereas infection with cagA-positive strains might result in severe gastric inflammation and gastric cancer. Numerous medicinal plants have been reported for their anti-H. pylori activity, and the relevant active compounds including polyphenols, flavonoids, quinones, coumarins, terpenoids, and alkaloids have been studied. The anti-H. pylori action mechanisms, including inhibition of enzymatic (urease, DNA gyrase, dihydrofolate reductase, N-acetyltransferase, and myeloperoxidase) and adhesive activities, high redox potential, and hydrophilic/hydrophobic natures of compounds, have also been discussed in detail. H. pylori-induced gastric inflammation may progress to superficial gastritis, atrophic gastritis, and finally gastric cancer. Many natural products have anti-H. pylori-induced inflammation activity and the relevant mechanisms include suppression of nuclear factor-κB and mitogen-activated protein kinase pathway activation and inhibition of oxidative stress. Anti-H. pylori induced gastric inflammatory effects of plant products, including quercetin, apigenin, carotenoids-rich algae, tea product, garlic extract, apple peel polyphenol, and finger-root extract, have been documented. In conclusion, many medicinal plant products possess anti-H. pylori activity as well as an anti-H. pylori-induced gastric inflammatory effect. Those plant products have showed great potential as pharmaceutical candidates for H. pylori eradication and H. pylori induced related gastric disease prevention.
Author Yuan-Chuen Wang
AuthorAffiliation Department of Food Science and Biotechnology,National Chung Hsing University
Author_xml – sequence: 1
  givenname: Yuan-Chuen
  surname: Wang
  fullname: Wang, Yuan-Chuen
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25132753$$D View this record in MEDLINE/PubMed
BookMark eNp9UUtvEzEQtlARTQs_gAvaI5cN49eufUGgCtpKRVzgbHltb-rKsVPbSZV_j0PTCjjgy1jj7zHj7wydxBQdQm8xLOnIxIeHu9VyR2DpKSwx0EG8QAtCsOyJYHCCFhhg7CUl4yk6K-UOgFDKySt0SjhuXU4X6NM3Z73xUYduE3SsnTbV73zddyl2Vy54k6bWcrnb7EPKvssu6OpsZ31xurjyGr2cdSjuzbGeo59fv_y4uOpvvl9eX3y-6Q0DqP0sqaQzMxgMFZOxnGLCRZvNEgsjCMcnCaOQg7N2MBYoxmIa2ITpDGTWlJ6jj4-6m-20dta4WLMOapP9Wue9Stqrv1-iv1WrtFMMUxCMNYH3R4Gc7reuVLX2xbjQtnZpWxTmw8CADHJs0Hd_ej2bPH1bA4yPAJNTKdnNyviqq08Hax8UBnUISLWAVAtItYDU74AaE__DfBL_H4ceObcpru59XD2TJIjDkRyYYJK3AVs93Bj9BRhepGU
CitedBy_id crossref_primary_10_1177_2058739220968308
crossref_primary_10_33808_clinexphealthsci_787845
crossref_primary_10_3390_molecules26082272
crossref_primary_10_3390_nu14214644
crossref_primary_10_1016_j_fbio_2024_104267
crossref_primary_10_3389_fmed_2023_1324473
crossref_primary_10_1016_j_jff_2018_03_027
crossref_primary_10_1590_0001_3765202320220427
crossref_primary_10_3390_ijms21020570
crossref_primary_10_1016_j_bjbas_2015_11_004
crossref_primary_10_4103_pr_pr_21_19
crossref_primary_10_3389_fmed_2024_1454902
crossref_primary_10_1111_1541_4337_12355
crossref_primary_10_1080_10412905_2022_2025464
crossref_primary_10_1007_s40495_017_0113_2
crossref_primary_10_3389_fphar_2024_1438193
crossref_primary_10_1016_j_medcle_2018_05_016
crossref_primary_10_3389_fphar_2020_583961
crossref_primary_10_3390_molecules28062448
crossref_primary_10_3390_antibiotics9050258
crossref_primary_10_1002_bab_2289
crossref_primary_10_1002_cbdv_202402247
crossref_primary_10_1016_j_jep_2023_116173
crossref_primary_10_3389_fcimb_2024_1360852
crossref_primary_10_17533_udea_acbi_v38n104a04
crossref_primary_10_3390_molecules25030586
crossref_primary_10_4162_nrp_2017_11_1_11
crossref_primary_10_1016_j_fitote_2018_03_001
crossref_primary_10_1016_j_jtcme_2018_05_001
crossref_primary_10_1002_cbdv_202301351
crossref_primary_10_1186_s12876_024_03564_6
crossref_primary_10_3390_ijms19082361
crossref_primary_10_3390_ijms241511906
crossref_primary_10_1016_j_phyplu_2021_100214
crossref_primary_10_4103_MJBL_MJBL_1156_23
crossref_primary_10_5306_wjco_v15_i5_653
crossref_primary_10_1080_13880209_2023_2200841
crossref_primary_10_3389_fphar_2023_1285754
crossref_primary_10_1016_j_jconrel_2020_09_025
crossref_primary_10_1186_s13065_019_0556_0
crossref_primary_10_3389_fonc_2022_881829
crossref_primary_10_1016_j_medcli_2017_09_014
crossref_primary_10_12998_wjcc_v4_i1_5
crossref_primary_10_3389_fmicb_2018_00005
crossref_primary_10_3390_medicines6020069
crossref_primary_10_1007_s11030_021_10371_8
crossref_primary_10_12998_wjcc_v9_i23_6591
crossref_primary_10_3389_fcimb_2021_709749
crossref_primary_10_1002_slct_202403703
crossref_primary_10_1177_1934578X19864212
crossref_primary_10_3892_or_2024_8765
crossref_primary_10_3390_pathogens11020191
crossref_primary_10_4236_ojmm_2019_94018
crossref_primary_10_1111_jam_14531
crossref_primary_10_1186_s12879_024_09424_8
crossref_primary_10_1016_j_procbio_2023_11_006
crossref_primary_10_1155_2020_2638362
crossref_primary_10_2991_efood_k_200211_001
crossref_primary_10_1186_s13020_021_00442_1
crossref_primary_10_1016_j_jep_2021_114855
crossref_primary_10_1021_acs_jnatprod_9b00149
crossref_primary_10_1016_j_bioorg_2021_104896
crossref_primary_10_1016_j_xphs_2020_11_021
crossref_primary_10_1155_2017_8379262
crossref_primary_10_3748_wjg_v21_i21_6499
crossref_primary_10_1016_j_ctim_2019_01_005
crossref_primary_10_1021_acsomega_2c02380
crossref_primary_10_3390_molecules26123654
crossref_primary_10_21307_PM_2019_60_2_13
crossref_primary_10_1002_cbdv_202301066
crossref_primary_10_1002_osi2_1172
crossref_primary_10_1016_j_indcrop_2020_112207
crossref_primary_10_2174_0122150838262681230920054706
crossref_primary_10_1371_journal_pone_0207193
crossref_primary_10_1002_cbdv_202300492
crossref_primary_10_1007_s12038_020_00078_7
crossref_primary_10_1007_s11051_025_06227_z
crossref_primary_10_1089_jmf_2017_0137
crossref_primary_10_5812_ajcmi_60463
crossref_primary_10_1016_j_heliyon_2024_e25232
crossref_primary_10_3390_nu12041000
crossref_primary_10_1089_jmf_2024_k_0091
crossref_primary_10_2174_1389201021666200807110849
crossref_primary_10_1080_11263504_2019_1578284
crossref_primary_10_3389_fmicb_2023_1134254
crossref_primary_10_1016_j_ijbiomac_2025_142133
crossref_primary_10_1016_j_bioorg_2024_108071
crossref_primary_10_1155_2017_9012929
crossref_primary_10_1038_s41598_019_47746_9
crossref_primary_10_3390_plants11192617
crossref_primary_10_1016_j_jep_2022_115930
crossref_primary_10_1007_s10735_024_10186_5
crossref_primary_10_2174_1568026623666221202112414
crossref_primary_10_1080_14787210_2022_1990041
crossref_primary_10_1016_j_jep_2025_119530
crossref_primary_10_1016_j_jep_2018_12_032
crossref_primary_10_1002_ffj_3559
crossref_primary_10_1007_s12272_019_01160_x
crossref_primary_10_1016_j_bbcan_2023_188998
crossref_primary_10_1016_j_ijbiomac_2025_141010
crossref_primary_10_1111_hel_12772
crossref_primary_10_1111_hel_12532
crossref_primary_10_1097_CEJ_0000000000000723
crossref_primary_10_3390_molecules26196078
crossref_primary_10_1016_j_jep_2024_118396
crossref_primary_10_1155_2018_1618051
crossref_primary_10_1111_jcmm_17967
crossref_primary_10_1016_j_bjp_2019_03_002
crossref_primary_10_3390_microbiolres14030075
crossref_primary_10_1007_s11094_021_02406_z
crossref_primary_10_1016_j_chmed_2024_09_001
crossref_primary_10_1016_j_freeradbiomed_2016_11_037
crossref_primary_10_1002_jsfa_13252
Cites_doi 10.1016/S0891-5849(02)00868-7
10.1128/IAI.69.8.5080-5087.2001
10.1016/j.jep.2009.07.009
10.1016/S1567-5769(03)00096-1
10.1038/35073084
10.1248/bpb.21.990
10.1016/s0016-5085(98)70090-3
10.1016/j.jep.2012.11.033
10.1248/jhs.54.81
10.1128/9781555818005
10.1016/j.femsim.2004.10.015
10.1002/ijc.24586
10.1152/ajpgi.2000.279.6.G1169
10.1128/AEM.66.5.2269-2273.2000
10.1016/j.bbrc.2003.09.066
10.1590/S1517-83822010000200007
10.1093/oxfordjournals.bmb.a011662
10.1016/j.arcmed.2011.04.009
10.1007/s002849900250
10.2174/157436206775269253
10.1021/up020472m
10.1016/j.jep.2009.05.016
10.1007/s10620-009-0828-y
10.1016/j.jopr.2013.09.002
10.1016/j.jep.2009.03.030
10.3389/fmicb.2010.00115
10.1128/CMR.12.4.564
10.3389/fcimb.2012.00092
10.5897/AJB08.595
10.1046/j.1523-5378.2003.00146.x
10.1248/bpb.19.182
10.1172/JCI30111
10.4049/jimmunol.0900664
10.1016/S0378-8741(98)00219-0
10.1111/j.1349-7006.2005.00130.x
10.1016/j.jep.2012.03.001
10.1111/j.1574-6968.1997.tb12777.x
10.1248/bpb.18.1053
10.1016/j.fct.2012.12.018
10.1016/j.jep.2008.12.021
10.1111/j.1572-0241.2001.05351.x
10.1128/AAC.01118-05
10.1021/np040188q
10.1007/s10620-013-2589-x
10.1146/annurev.physiol.60.1.619
10.1016/s0960-894x(00)00671-5
10.1016/s0924-8579(00)00205-3
10.1016/S0924-8579(01)00352-1
10.1016/j.foodres.2011.02.017
10.1111/j.1348-0421.2000.tb01240.x
10.1016/s0092-8674(00)81698-0
10.1111/j.1523-5378.2007.00521.x
10.1016/j.jep.2005.09.014
10.1016/j.jep.2013.02.032
10.1016/j.phytochem.2006.07.017
10.1016/S0304-3835(02)
10.1038/nrc2857
10.1016/j.jep.2006.06.001
10.1002/ptr.1776
10.1016/S0378-1097(03)00439-7
10.1016/j.fitote.2012.03.019
10.1002/ptr.1640
10.1016/j.chom.2007.09.005
10.1002/ptr.1830
10.1002/ptr.1265
10.1111/j.1550-7408.2002.
10.1016/j.jep.2007.07.022
10.1016/j.tet.2005.12.041
10.3748/wjg.v11.i47.7499
10.1152/physrev.00039.2009
10.1016/s1082-7579(98)00012-0
10.1078/0944-7113-00004
10.1016/S0378-8741(01)00184-2
10.1016/j.jep.2010.01.060
10.1007/s00535-008-2184-7
10.3109/00365529109098222
10.1002/ptr.2933
10.1038/nrgastro.2010.154
10.1038/sj.bjp.0706421
10.1093/jac/37.5.919
10.1128/AEM.71.12.8558-8564.2005
10.1016/j.jep.2005.01.020
10.3389/fcimb.2012.00037
10.1142/S0192415X09007181
10.1016/S0960-894X(99)00141-9
10.1111/j.1523-5378.2009.00724.x.
10.1016/j.jep.2005.11.005
10.1012/jf100274g
10.1016/j.it.2004.03.008
10.1093/jb/mvh181
10.1016/S0928-8244(03)00008-7
10.1056/NEJM200109133451111
10.3390/molecules18022135
10.1152/ajpcell.2000.278.3.C451
10.1016/j.phymed.2006.12.008
10.3390/molecules14030939
10.1093/ecam/nep147
10.1038/nri1312
10.1016/j.femsim.2004.09.008
10.1007/s005350170147
10.1126/science.284.5418.1328
10.1016/S0024-3205(02)01864-7
10.1016/S0378-8741(03)00217-4
10.1007/s100960100611
10.1016/j.tim.2012.01.008
10.1590/S0036-36342001000300010
10.1016/0928-8244(95)00120-4
10.1002/(SICI)1099-1263(199803/04)
10.16/j.ijantimicag.2011.05.002
10.1006/abbi.2001.2642
10.1111/j.1440-1746.2009.06127.x
10.17348/era.4.0.159-166
10.1016/j.biopha.2008.08.002
10.1016/s0934-8840(97)80076-x
10.1016/S0732-8893(99)00039-5
10.1016/j.bbrc.2004.02.158
10.1021/jf3035034
10.1016/j.jep.2017.04.015
10.1016/j.bmcl.2006.08.043
10.1016/S0924-8579(00)00315-0
10.1016/j.jep.2008.11.001
10.1046/j.1440-1746.2000
10.1016/j.jep.2007.08.037
10.1016/s1068-607x(98)00155-3
10.1016/j.tim.2004.12.007
10.1016/S0016-5085(11)61257-2
10.1016/j.jep.2013.11.040
10.1016/S0378-8741(97)00109-8
10.1016/j.ijantimicag.2009.01.010
10.1046/j.1523-1755.61.s80.1.x
10.1016/j.phymed.2005.06.008
ContentType Journal Article
Copyright 2014 Baishideng Publishing Group Inc. All rights reserved. 2014
Copyright_xml – notice: 2014 Baishideng Publishing Group Inc. All rights reserved. 2014
DBID 2RA
92L
CQIGP
W91
~WA
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.3748/wjg.v20.i30.10368
DatabaseName 中文科技期刊数据库
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Medicinal plant activity on Helicobacter pylori related diseases
EISSN 2219-2840
EndPage 10382
ExternalDocumentID PMC4130844
25132753
10_3748_wjg_v20_i30_10368
90888889504849525148484954
Genre Journal Article
Review
GroupedDBID ---
123
29R
2B.
2C~
2RA
2WC
36B
53G
5VR
8WL
92F
92I
92L
93N
93R
AAKDD
ACGFO
AENEX
AFUIB
ALMA_UNASSIGNED_HOLDINGS
CCEZO
CHBEP
CIEJG
CQIGP
CS3
CW9
DIK
DU5
E3Z
EBS
EJD
EMB
F5P
FA0
FRP
GX1
HYE
M~E
OK1
P2P
RNS
RPM
SV3
TCJ
TGQ
TR2
W91
WFFXF
XSB
~WA
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c400t-f9393f4c10c38bcd531258932d2d0708e5b907896edd6cd03118b64b13f02fa33
ISSN 1007-9327
2219-2840
IngestDate Thu Aug 21 18:29:33 EDT 2025
Fri Jul 11 08:35:00 EDT 2025
Thu Apr 03 07:01:19 EDT 2025
Tue Jul 01 01:53:35 EDT 2025
Thu Apr 24 23:08:50 EDT 2025
Wed Feb 14 10:28:40 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 30
Keywords Nuclear factor-κB pathway
Helicobacter pylori
Virulence factor
Active compound
Inflammation
Gastric cancer
Mechanism
Medicinal plant
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c400t-f9393f4c10c38bcd531258932d2d0708e5b907896edd6cd03118b64b13f02fa33
Notes Yuan-Chuen Wang;Department of Food Science and Biotechnology,National Chung Hsing University
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Correspondence to: Yuan-Chuen Wang, Professor, PhD, Department of Food Science and Biotechnology, National Chung Hsing University, 250 Kuo-Kuang Rd., Taichung 402, Taiwan. ycwang@nchu.edu.tw
Author contributions: Wang YC designed and performed this research, and wrote this paper.
Telephone: +886-4-22840385 Fax: +886-4-22854053
PMID 25132753
PQID 1566402697
PQPubID 23479
PageCount 15
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4130844
proquest_miscellaneous_1566402697
pubmed_primary_25132753
crossref_citationtrail_10_3748_wjg_v20_i30_10368
crossref_primary_10_3748_wjg_v20_i30_10368
chongqing_primary_90888889504849525148484954
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-08-14
PublicationDateYYYYMMDD 2014-08-14
PublicationDate_xml – month: 08
  year: 2014
  text: 2014-08-14
  day: 14
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle World journal of gastroenterology : WJG
PublicationTitleAlternate World Journal of Gastroenterology
PublicationYear 2014
Publisher Baishideng Publishing Group Inc
Publisher_xml – name: Baishideng Publishing Group Inc
References ref57
ref56
ref59
ref58
ref53
ref52
ref55
ref54
ref51
ref50
ref46
ref45
ref48
ref47
ref42
ref41
ref44
ref43
ref49
ref8
ref7
ref9
ref4
ref3
ref6
ref5
ref100
ref101
ref40
ref35
ref34
ref37
ref36
ref31
ref30
ref33
ref32
ref39
ref38
ref24
ref23
ref26
ref25
ref20
ref22
ref21
ref28
ref27
ref29
ref13
ref12
ref15
ref128
ref14
ref129
ref97
ref126
ref96
ref127
ref11
ref99
ref124
ref10
ref98
ref125
ref17
ref16
ref19
ref18
ref93
ref133
ref92
ref134
ref95
ref131
ref94
ref132
ref130
ref91
ref90
ref89
ref139
ref86
ref137
ref85
ref138
ref88
ref135
ref87
ref136
ref82
ref81
ref84
ref83
ref80
ref79
ref108
ref78
ref109
ref106
ref107
ref75
ref104
ref74
ref105
ref77
ref102
ref76
ref103
ref2
ref1
ref71
ref111
ref70
ref112
ref73
ref72
ref110
ref68
ref119
ref67
ref117
ref69
ref118
ref64
ref115
ref63
ref116
ref66
ref113
ref65
ref114
ref60
ref122
ref123
ref62
ref120
ref61
ref121
10788416 - Appl Environ Microbiol. 2000 May;66(5):2269-73
20938460 - Nat Rev Gastroenterol Hepatol. 2010 Nov;7(11):629-41
10712233 - Am J Physiol Cell Physiol. 2000 Mar;278(3):C451-62
16266794 - J Ethnopharmacol. 2006 Feb 20;103(3):461-7
15814268 - J Ethnopharmacol. 2005 Apr 26;98(3):329-33
11389469 - Nat Rev Mol Cell Biol. 2001 Jun;2(6):457-66
9435101 - FEMS Microbiol Lett. 1997 Dec 15;157(2):229-32
8739190 - FEMS Immunol Med Microbiol. 1996 Apr;13(4):273-7
19255552 - Molecules. 2009;14(3):939-52
15974602 - J Nat Prod. 2005 Jun;68(6):819-24
23266501 - Food Chem Toxicol. 2013 Mar;53:376-83
18600388 - J Gastroenterol. 2008;43(6):441-7
19653313 - Phytother Res. 2010 May;24(5):649-56
12672149 - Phytother Res. 2003 Mar;17(3):217-21
23220194 - J Ethnopharmacol. 2013 Jan 30;145(2):581-6
6134060 - Lancet. 1983 Jun 4;1(8336):1273-5
9241802 - Zentralbl Bakteriol. 1997 Jun;286(1):63-7
15680765 - Trends Microbiol. 2005 Feb;13(2):64-71
16247412 - Br J Pharmacol. 2005 Dec;146(8):1139-47
11292234 - Phytomedicine. 2001 Jan;8(1):16-23
10711594 - Microbiol Immunol. 2000;44(1):9-15
18809274 - Biomed Pharmacother. 2008 Nov;62(9):659-66
11310443 - Int J Med Microbiol. 2001 Mar;290(8):647-58
11452701 - Salud Publica Mex. 2001 May-Jun;43(3):237-47
22919629 - Front Cell Infect Microbiol. 2012;2:37
19162157 - J Ethnopharmacol. 2009 Mar 18;122(2):402-5
21687723 - Front Microbiol. 2010 Nov 23;1:115
10334982 - Science. 1999 May 21;284(5418):1328-33
11297852 - J Ethnopharmacol. 2001 May;75(2-3):203-5
19610061 - Int J Cancer. 2009 Oct 15;125(8):1786-95
10390246 - Antimicrob Agents Chemother. 1999 Jul;43(7):1788-91
11556306 - N Engl J Med. 2001 Sep 13;345(11):829-32
16332847 - Appl Environ Microbiol. 2005 Dec;71(12):8558-64
15173992 - Phytother Res. 2004 May;18(5):358-61
9507900 - J Ethnopharmacol. 1998 Jan;59(3):167-72
19386474 - Int J Antimicrob Agents. 2009 Jul;34(1):50-9
11795892 - Arch Biochem Biophys. 2002 Jan 15;397(2):342-4
12615708 - Cancer Res. 2003 Mar 1;63(5):951-7
12810355 - Int Immunopharmacol. 2003 Jul;3(7):979-86
1458460 - Cancer Res. 1992 Dec 15;52(24):6735-40
9797374 - Gastroenterology. 1998 Nov;115(5):1186-96
8737142 - J Antimicrob Chemother. 1996 May;37(5):919-29
19889077 - Helicobacter. 2009 Dec;14(6):588-95
21722823 - Arch Med Res. 2011 Apr;42(3):252-7
20007577 - J Immunol. 2009 Dec 15;183(12):8099-109
20486708 - J Agric Food Chem. 2010 Jun 23;58(12):7172-9
11091043 - Int J Antimicrob Agents. 2000 Nov;16(3):245-8
10515903 - Clin Microbiol Rev. 1999 Oct;12(4):564-82
19041711 - J Ethnopharmacol. 2009 Jan 21;121(2):286-91
16437723 - World J Gastroenterol. 2005 Dec 21;11(47):7499-507
15039755 - Nat Rev Immunol. 2004 Mar;4(3):181-9
19655409 - Am J Chin Med. 2009;37(4):713-22
12963139 - J Ethnopharmacol. 2003 Oct;88(2-3):175-9
17760719 - Helicobacter. 2007 Oct;12(5):510-7
23434867 - Molecules. 2013;18(2):2135-49
9558479 - Annu Rev Physiol. 1998;60:619-42
11165121 - Int J Antimicrob Agents. 2001 Feb;17(2):151-4
14550260 - Biochem Biophys Res Commun. 2003 Oct 24;310(3):715-9
10328294 - Bioorg Med Chem Lett. 1999 Apr 19;9(8):1109-12
22364673 - Trends Microbiol. 2012 Apr;20(4):165-74
15044093 - Biochem Biophys Res Commun. 2004 Apr 16;316(4):1065-72
9462956 - Curr Microbiol. 1997 Nov;35(5):262-6
15671482 - J Biochem. 2004 Dec;136(6):741-6
17200707 - J Clin Invest. 2007 Jan;117(1):60-9
16723594 - Antimicrob Agents Chemother. 2006 Jun;50(6):2237-9
11463533 - Int J Antimicrob Agents. 2001 Jul;18(1):85-8
12127165 - Life Sci. 2002 Aug 9;71(12):1449-63
20495574 - Nat Rev Cancer. 2010 Jun;10(6):403-14
16359837 - J Ethnopharmacol. 2006 Apr 21;105(1-2):255-62
17085295 - Phytomedicine. 2006 Nov;13(9-10):724-7
23500884 - J Ethnopharmacol. 2013 May 2;147(1):204-7
11211212 - J Gastroenterol. 2001 Jan;36(1):5-9
7715070 - IARC Monogr Eval Carcinog Risks Hum. 1994;61:177-240
24031496 - Braz J Microbiol. 2010 Apr;41(2):304-9
11774979 - Am J Gastroenterol. 2001 Dec;96(12):3454-5
16870372 - J Ethnopharmacol. 2006 Dec 6;108(3):457-61
12727360 - FEMS Immunol Med Microbiol. 2003 May 15;36(1-2):9-17
19773391 - Evid Based Complement Alternat Med. 2011;2011:704721
9865693 - Cell. 1998 Dec 11;95(6):749-58
8535394 - Biol Pharm Bull. 1995 Aug;18(8):1053-6
10473175 - J Ethnopharmacol. 1999 Sep;66(3):289-93
19607905 - J Ethnopharmacol. 2009 Sep 7;125(2):218-23
20152892 - J Ethnopharmacol. 2010 Apr 21;128(3):583-9
14598616 - In Vivo. 2003 Sep-Oct;17(5):509-12
17913416 - J Ethnopharmacol. 2007 Dec 3;114(3):452-7
17350240 - Phytomedicine. 2007 Apr;14(4):285-8
22891951 - J Agric Food Chem. 2012 Sep 12;60(36):9062-73
8850302 - Biol Pharm Bull. 1996 Feb;19(2):182-7
16945527 - Bioorg Med Chem Lett. 2006 Nov 1;16(21):5523-5
19467317 - J Ethnopharmacol. 2009 Jul 30;124(3):642-5
15681161 - FEMS Immunol Med Microbiol. 2005 Feb 1;43(2):295-300
15934015 - Phytother Res. 2005 Mar;19(3):198-202
12762812 - J Nat Prod. 2003 May;66(5):699-702
9604436 - Br Med Bull. 1998;54(1):105-20
18005743 - Cell Host Microbe. 2007 Oct 11;2(4):250-63
12752733 - Helicobacter. 2003 Jun;8(3):207-15
24374236 - J Ethnopharmacol. 2014 Feb 12;151(3):1031-9
21752604 - Int J Antimicrob Agents. 2011 Oct;38(4):319-24
9570694 - J Appl Toxicol. 1998 Mar-Apr;18(2):117-23
12892889 - FEMS Microbiol Lett. 2003 Jul 29;224(2):247-53
20388956 - J Physiol Pharmacol. 2009 Dec;60 Suppl 7:131-7
22433535 - J Ethnopharmacol. 2012 May 7;141(1):403-10
10824880 - J Gastroenterol Hepatol. 2000 Apr;15(4):374-80
16367902 - Cancer Sci. 2005 Dec;96(12):835-43
19495976 - Dig Dis Sci. 2010 Apr;55(4):988-96
15708315 - FEMS Immunol Med Microbiol. 2005 Mar 1;43(3):407-12
10529879 - Diagn Microbiol Infect Dis. 1999 Sep;35(1):33-6
17768020 - J Ethnopharmacol. 2007 Oct 8;114(1):72-7
22465506 - Fitoterapia. 2012 Jul;83(5):872-6
20664074 - Physiol Rev. 2010 Jul;90(3):831-58
17537603 - J Ethnopharmacol. 2007 Jul 25;112(3):537-44
16521108 - Phytother Res. 2006 Mar;20(3):187-90
9781854 - Biol Pharm Bull. 1998 Sep;21(9):990-2
11447189 - Infect Immun. 2001 Aug;69(8):5080-7
15145317 - Trends Immunol. 2004 Jun;25(6):280-8
11093939 - Am J Physiol Gastrointest Liver Physiol. 2000 Dec;279(6):G1169-76
22919683 - Front Cell Infect Microbiol. 2012;2:92
19501278 - J Ethnopharmacol. 2009 Jun 25;123(3):452-8
20136974 - J Gastroenterol Hepatol. 2010 Jan;25(1):194-202
11982824 - Kidney Int Suppl. 2002 May;(80):109-14
16950485 - Phytochemistry. 2006 Dec;67(24):2623-9
12359352 - Cancer Lett. 2002 Dec 10;187(1-2):61-8
11783701 - Eur J Clin Microbiol Infect Dis. 2001 Nov;20(11):820-3
11212121 - Bioorg Med Chem Lett. 2001 Feb 12;11(3):403-6
12126754 - Free Radic Biol Med. 2002 Aug 1;33(3):323-36
23423500 - Dig Dis Sci. 2013 Jul;58(7):1830-7
References_xml – ident: ref27
  doi: 10.1016/S0891-5849(02)00868-7
– ident: ref1
– ident: ref16
  doi: 10.1128/IAI.69.8.5080-5087.2001
– ident: ref116
  doi: 10.1016/j.jep.2009.07.009
– ident: ref134
  doi: 10.1016/S1567-5769(03)00096-1
– ident: ref33
  doi: 10.1038/35073084
– ident: ref86
  doi: 10.1248/bpb.21.990
– ident: ref36
  doi: 10.1016/s0016-5085(98)70090-3
– ident: ref119
  doi: 10.1016/j.jep.2012.11.033
– ident: ref77
  doi: 10.1248/jhs.54.81
– ident: ref6
  doi: 10.1128/9781555818005
– ident: ref79
  doi: 10.1016/j.femsim.2004.10.015
– ident: ref128
  doi: 10.1002/ijc.24586
– ident: ref37
  doi: 10.1152/ajpgi.2000.279.6.G1169
– ident: ref109
  doi: 10.1128/AEM.66.5.2269-2273.2000
– ident: ref135
  doi: 10.1016/j.bbrc.2003.09.066
– ident: ref75
  doi: 10.1590/S1517-83822010000200007
– ident: ref9
  doi: 10.1093/oxfordjournals.bmb.a011662
– ident: ref70
  doi: 10.1016/j.arcmed.2011.04.009
– ident: ref98
  doi: 10.1007/s002849900250
– ident: ref28
  doi: 10.2174/157436206775269253
– ident: ref92
  doi: 10.1021/up020472m
– ident: ref63
  doi: 10.1016/j.jep.2009.05.016
– ident: ref34
  doi: 10.1007/s10620-009-0828-y
– ident: ref100
  doi: 10.1016/j.jopr.2013.09.002
– ident: ref114
  doi: 10.1016/j.jep.2009.03.030
– ident: ref19
  doi: 10.3389/fmicb.2010.00115
– ident: ref112
  doi: 10.1128/CMR.12.4.564
– ident: ref15
  doi: 10.3389/fcimb.2012.00092
– ident: ref68
  doi: 10.5897/AJB08.595
– ident: ref81
  doi: 10.1046/j.1523-5378.2003.00146.x
– ident: ref43
  doi: 10.1248/bpb.19.182
– ident: ref24
  doi: 10.1172/JCI30111
– ident: ref32
  doi: 10.4049/jimmunol.0900664
– ident: ref59
  doi: 10.1016/S0378-8741(98)00219-0
– ident: ref21
  doi: 10.1111/j.1349-7006.2005.00130.x
– ident: ref3
– ident: ref127
  doi: 10.1016/j.jep.2012.03.001
– ident: ref47
  doi: 10.1111/j.1574-6968.1997.tb12777.x
– ident: ref108
– ident: ref44
  doi: 10.1248/bpb.18.1053
– ident: ref122
  doi: 10.1016/j.fct.2012.12.018
– ident: ref53
  doi: 10.1016/j.jep.2008.12.021
– ident: ref89
  doi: 10.1111/j.1572-0241.2001.05351.x
– ident: ref97
  doi: 10.1128/AAC.01118-05
– ident: ref104
  doi: 10.1021/np040188q
– ident: ref20
  doi: 10.1007/s10620-013-2589-x
– ident: ref40
  doi: 10.1146/annurev.physiol.60.1.619
– ident: ref46
  doi: 10.1016/s0960-894x(00)00671-5
– ident: ref49
  doi: 10.1016/s0924-8579(00)00205-3
– ident: ref65
  doi: 10.1016/S0924-8579(01)00352-1
– ident: ref88
  doi: 10.1016/j.foodres.2011.02.017
– ident: ref107
  doi: 10.1111/j.1348-0421.2000.tb01240.x
– ident: ref26
  doi: 10.1016/s0092-8674(00)81698-0
– ident: ref124
  doi: 10.1111/j.1523-5378.2007.00521.x
– ident: ref84
  doi: 10.1016/j.jep.2005.09.014
– ident: ref83
  doi: 10.1016/j.jep.2013.02.032
– ident: ref102
  doi: 10.1016/j.phytochem.2006.07.017
– ident: ref136
  doi: 10.1016/S0304-3835(02)
– ident: ref12
  doi: 10.1038/nrc2857
– ident: ref93
  doi: 10.1016/j.jep.2006.06.001
– ident: ref54
  doi: 10.1002/ptr.1776
– ident: ref110
  doi: 10.1016/S0378-1097(03)00439-7
– ident: ref64
  doi: 10.1016/j.fitote.2012.03.019
– ident: ref72
  doi: 10.1002/ptr.1640
– ident: ref18
  doi: 10.1016/j.chom.2007.09.005
– ident: ref62
  doi: 10.1002/ptr.1830
– ident: ref76
  doi: 10.1002/ptr.1265
– ident: ref85
  doi: 10.1111/j.1550-7408.2002.
– ident: ref67
  doi: 10.1016/j.jep.2007.07.022
– ident: ref87
  doi: 10.1016/j.tet.2005.12.041
– ident: ref115
  doi: 10.3748/wjg.v11.i47.7499
– ident: ref29
  doi: 10.1152/physrev.00039.2009
– ident: ref48
  doi: 10.1016/s1082-7579(98)00012-0
– ident: ref91
  doi: 10.1078/0944-7113-00004
– ident: ref58
  doi: 10.1016/S0378-8741(01)00184-2
– ident: ref120
  doi: 10.1016/j.jep.2010.01.060
– ident: ref133
  doi: 10.1007/s00535-008-2184-7
– ident: ref5
  doi: 10.3109/00365529109098222
– ident: ref74
  doi: 10.1002/ptr.2933
– ident: ref7
  doi: 10.1038/nrgastro.2010.154
– ident: ref125
  doi: 10.1038/sj.bjp.0706421
– ident: ref105
  doi: 10.1093/jac/37.5.919
– ident: ref113
  doi: 10.1128/AEM.71.12.8558-8564.2005
– ident: ref56
  doi: 10.1016/j.jep.2005.01.020
– ident: ref14
  doi: 10.3389/fcimb.2012.00037
– ident: ref52
  doi: 10.1142/S0192415X09007181
– ident: ref57
  doi: 10.1016/S0960-894X(99)00141-9
– ident: ref123
  doi: 10.1111/j.1523-5378.2009.00724.x.
– ident: ref96
  doi: 10.1016/j.jep.2005.11.005
– ident: ref137
  doi: 10.1012/jf100274g
– ident: ref17
– ident: ref30
  doi: 10.1016/j.it.2004.03.008
– ident: ref13
  doi: 10.1093/jb/mvh181
– ident: ref111
  doi: 10.1016/S0928-8244(03)00008-7
– ident: ref23
  doi: 10.1056/NEJM200109133451111
– ident: ref61
  doi: 10.3390/molecules18022135
– ident: ref25
  doi: 10.1152/ajpcell.2000.278.3.C451
– ident: ref2
– ident: ref117
  doi: 10.1016/j.phymed.2006.12.008
– ident: ref99
  doi: 10.3390/molecules14030939
– ident: ref95
  doi: 10.1093/ecam/nep147
– ident: ref35
  doi: 10.1038/nri1312
– ident: ref80
  doi: 10.1016/j.femsim.2004.09.008
– ident: ref132
  doi: 10.1007/s005350170147
– ident: ref4
  doi: 10.1126/science.284.5418.1328
– ident: ref94
  doi: 10.1016/S0024-3205(02)01864-7
– ident: ref78
  doi: 10.1016/S0378-8741(03)00217-4
– ident: ref50
  doi: 10.1007/s100960100611
– ident: ref11
  doi: 10.1016/j.tim.2012.01.008
– ident: ref130
– ident: ref8
  doi: 10.1590/S0036-36342001000300010
– ident: ref73
  doi: 10.1016/0928-8244(95)00120-4
– ident: ref121
  doi: 10.1002/(SICI)1099-1263(199803/04)
– ident: ref106
  doi: 10.16/j.ijantimicag.2011.05.002
– ident: ref38
  doi: 10.1006/abbi.2001.2642
– ident: ref31
  doi: 10.1111/j.1440-1746.2009.06127.x
– ident: ref138
  doi: 10.17348/era.4.0.159-166
– ident: ref129
  doi: 10.1016/j.biopha.2008.08.002
– ident: ref22
– ident: ref103
  doi: 10.1016/s0934-8840(97)80076-x
– ident: ref42
  doi: 10.1016/S0732-8893(99)00039-5
– ident: ref101
– ident: ref131
  doi: 10.1016/j.bbrc.2004.02.158
– ident: ref90
  doi: 10.1021/jf3035034
– ident: ref126
  doi: 10.1016/j.jep.2017.04.015
– ident: ref82
  doi: 10.1016/j.bmcl.2006.08.043
– ident: ref41
  doi: 10.1016/S0924-8579(00)00315-0
– ident: ref55
  doi: 10.1016/j.jep.2008.11.001
– ident: ref118
  doi: 10.1046/j.1440-1746.2000
– ident: ref69
  doi: 10.1016/j.jep.2007.08.037
– ident: ref45
  doi: 10.1016/s1068-607x(98)00155-3
– ident: ref10
  doi: 10.1016/j.tim.2004.12.007
– ident: ref51
  doi: 10.1016/S0016-5085(11)61257-2
– ident: ref139
  doi: 10.1016/j.jep.2013.11.040
– ident: ref71
  doi: 10.1016/S0378-8741(97)00109-8
– ident: ref66
  doi: 10.1016/j.ijantimicag.2009.01.010
– ident: ref39
  doi: 10.1046/j.1523-1755.61.s80.1.x
– ident: ref60
  doi: 10.1016/j.phymed.2005.06.008
– reference: 17537603 - J Ethnopharmacol. 2007 Jul 25;112(3):537-44
– reference: 24031496 - Braz J Microbiol. 2010 Apr;41(2):304-9
– reference: 8737142 - J Antimicrob Chemother. 1996 May;37(5):919-29
– reference: 20664074 - Physiol Rev. 2010 Jul;90(3):831-58
– reference: 20495574 - Nat Rev Cancer. 2010 Jun;10(6):403-14
– reference: 1458460 - Cancer Res. 1992 Dec 15;52(24):6735-40
– reference: 6134060 - Lancet. 1983 Jun 4;1(8336):1273-5
– reference: 23500884 - J Ethnopharmacol. 2013 May 2;147(1):204-7
– reference: 10328294 - Bioorg Med Chem Lett. 1999 Apr 19;9(8):1109-12
– reference: 19610061 - Int J Cancer. 2009 Oct 15;125(8):1786-95
– reference: 22891951 - J Agric Food Chem. 2012 Sep 12;60(36):9062-73
– reference: 8739190 - FEMS Immunol Med Microbiol. 1996 Apr;13(4):273-7
– reference: 9604436 - Br Med Bull. 1998;54(1):105-20
– reference: 16870372 - J Ethnopharmacol. 2006 Dec 6;108(3):457-61
– reference: 7715070 - IARC Monogr Eval Carcinog Risks Hum. 1994;61:177-240
– reference: 15934015 - Phytother Res. 2005 Mar;19(3):198-202
– reference: 12359352 - Cancer Lett. 2002 Dec 10;187(1-2):61-8
– reference: 15173992 - Phytother Res. 2004 May;18(5):358-61
– reference: 17200707 - J Clin Invest. 2007 Jan;117(1):60-9
– reference: 18809274 - Biomed Pharmacother. 2008 Nov;62(9):659-66
– reference: 12762812 - J Nat Prod. 2003 May;66(5):699-702
– reference: 11982824 - Kidney Int Suppl. 2002 May;(80):109-14
– reference: 9435101 - FEMS Microbiol Lett. 1997 Dec 15;157(2):229-32
– reference: 17350240 - Phytomedicine. 2007 Apr;14(4):285-8
– reference: 10473175 - J Ethnopharmacol. 1999 Sep;66(3):289-93
– reference: 10788416 - Appl Environ Microbiol. 2000 May;66(5):2269-73
– reference: 15671482 - J Biochem. 2004 Dec;136(6):741-6
– reference: 16945527 - Bioorg Med Chem Lett. 2006 Nov 1;16(21):5523-5
– reference: 14550260 - Biochem Biophys Res Commun. 2003 Oct 24;310(3):715-9
– reference: 11556306 - N Engl J Med. 2001 Sep 13;345(11):829-32
– reference: 16266794 - J Ethnopharmacol. 2006 Feb 20;103(3):461-7
– reference: 11389469 - Nat Rev Mol Cell Biol. 2001 Jun;2(6):457-66
– reference: 16359837 - J Ethnopharmacol. 2006 Apr 21;105(1-2):255-62
– reference: 9570694 - J Appl Toxicol. 1998 Mar-Apr;18(2):117-23
– reference: 19041711 - J Ethnopharmacol. 2009 Jan 21;121(2):286-91
– reference: 14598616 - In Vivo. 2003 Sep-Oct;17(5):509-12
– reference: 9241802 - Zentralbl Bakteriol. 1997 Jun;286(1):63-7
– reference: 12963139 - J Ethnopharmacol. 2003 Oct;88(2-3):175-9
– reference: 11211212 - J Gastroenterol. 2001 Jan;36(1):5-9
– reference: 20938460 - Nat Rev Gastroenterol Hepatol. 2010 Nov;7(11):629-41
– reference: 19653313 - Phytother Res. 2010 May;24(5):649-56
– reference: 23220194 - J Ethnopharmacol. 2013 Jan 30;145(2):581-6
– reference: 19607905 - J Ethnopharmacol. 2009 Sep 7;125(2):218-23
– reference: 10824880 - J Gastroenterol Hepatol. 2000 Apr;15(4):374-80
– reference: 19255552 - Molecules. 2009;14(3):939-52
– reference: 22364673 - Trends Microbiol. 2012 Apr;20(4):165-74
– reference: 15708315 - FEMS Immunol Med Microbiol. 2005 Mar 1;43(3):407-12
– reference: 19501278 - J Ethnopharmacol. 2009 Jun 25;123(3):452-8
– reference: 15974602 - J Nat Prod. 2005 Jun;68(6):819-24
– reference: 19889077 - Helicobacter. 2009 Dec;14(6):588-95
– reference: 24374236 - J Ethnopharmacol. 2014 Feb 12;151(3):1031-9
– reference: 16247412 - Br J Pharmacol. 2005 Dec;146(8):1139-47
– reference: 16950485 - Phytochemistry. 2006 Dec;67(24):2623-9
– reference: 12727360 - FEMS Immunol Med Microbiol. 2003 May 15;36(1-2):9-17
– reference: 16723594 - Antimicrob Agents Chemother. 2006 Jun;50(6):2237-9
– reference: 11297852 - J Ethnopharmacol. 2001 May;75(2-3):203-5
– reference: 11165121 - Int J Antimicrob Agents. 2001 Feb;17(2):151-4
– reference: 8535394 - Biol Pharm Bull. 1995 Aug;18(8):1053-6
– reference: 19162157 - J Ethnopharmacol. 2009 Mar 18;122(2):402-5
– reference: 12752733 - Helicobacter. 2003 Jun;8(3):207-15
– reference: 19773391 - Evid Based Complement Alternat Med. 2011;2011:704721
– reference: 11091043 - Int J Antimicrob Agents. 2000 Nov;16(3):245-8
– reference: 16437723 - World J Gastroenterol. 2005 Dec 21;11(47):7499-507
– reference: 23423500 - Dig Dis Sci. 2013 Jul;58(7):1830-7
– reference: 12615708 - Cancer Res. 2003 Mar 1;63(5):951-7
– reference: 18005743 - Cell Host Microbe. 2007 Oct 11;2(4):250-63
– reference: 15681161 - FEMS Immunol Med Microbiol. 2005 Feb 1;43(2):295-300
– reference: 12810355 - Int Immunopharmacol. 2003 Jul;3(7):979-86
– reference: 16521108 - Phytother Res. 2006 Mar;20(3):187-90
– reference: 20486708 - J Agric Food Chem. 2010 Jun 23;58(12):7172-9
– reference: 23266501 - Food Chem Toxicol. 2013 Mar;53:376-83
– reference: 9781854 - Biol Pharm Bull. 1998 Sep;21(9):990-2
– reference: 20152892 - J Ethnopharmacol. 2010 Apr 21;128(3):583-9
– reference: 16367902 - Cancer Sci. 2005 Dec;96(12):835-43
– reference: 23434867 - Molecules. 2013;18(2):2135-49
– reference: 12127165 - Life Sci. 2002 Aug 9;71(12):1449-63
– reference: 10712233 - Am J Physiol Cell Physiol. 2000 Mar;278(3):C451-62
– reference: 11093939 - Am J Physiol Gastrointest Liver Physiol. 2000 Dec;279(6):G1169-76
– reference: 17085295 - Phytomedicine. 2006 Nov;13(9-10):724-7
– reference: 10515903 - Clin Microbiol Rev. 1999 Oct;12(4):564-82
– reference: 15145317 - Trends Immunol. 2004 Jun;25(6):280-8
– reference: 17913416 - J Ethnopharmacol. 2007 Dec 3;114(3):452-7
– reference: 11452701 - Salud Publica Mex. 2001 May-Jun;43(3):237-47
– reference: 15044093 - Biochem Biophys Res Commun. 2004 Apr 16;316(4):1065-72
– reference: 16332847 - Appl Environ Microbiol. 2005 Dec;71(12):8558-64
– reference: 11310443 - Int J Med Microbiol. 2001 Mar;290(8):647-58
– reference: 10529879 - Diagn Microbiol Infect Dis. 1999 Sep;35(1):33-6
– reference: 10711594 - Microbiol Immunol. 2000;44(1):9-15
– reference: 15680765 - Trends Microbiol. 2005 Feb;13(2):64-71
– reference: 8850302 - Biol Pharm Bull. 1996 Feb;19(2):182-7
– reference: 22919683 - Front Cell Infect Microbiol. 2012;2:92
– reference: 11463533 - Int J Antimicrob Agents. 2001 Jul;18(1):85-8
– reference: 22465506 - Fitoterapia. 2012 Jul;83(5):872-6
– reference: 15814268 - J Ethnopharmacol. 2005 Apr 26;98(3):329-33
– reference: 12672149 - Phytother Res. 2003 Mar;17(3):217-21
– reference: 19495976 - Dig Dis Sci. 2010 Apr;55(4):988-96
– reference: 9462956 - Curr Microbiol. 1997 Nov;35(5):262-6
– reference: 12892889 - FEMS Microbiol Lett. 2003 Jul 29;224(2):247-53
– reference: 21752604 - Int J Antimicrob Agents. 2011 Oct;38(4):319-24
– reference: 11447189 - Infect Immun. 2001 Aug;69(8):5080-7
– reference: 20388956 - J Physiol Pharmacol. 2009 Dec;60 Suppl 7:131-7
– reference: 11795892 - Arch Biochem Biophys. 2002 Jan 15;397(2):342-4
– reference: 21687723 - Front Microbiol. 2010 Nov 23;1:115
– reference: 20007577 - J Immunol. 2009 Dec 15;183(12):8099-109
– reference: 22919629 - Front Cell Infect Microbiol. 2012;2:37
– reference: 20136974 - J Gastroenterol Hepatol. 2010 Jan;25(1):194-202
– reference: 19655409 - Am J Chin Med. 2009;37(4):713-22
– reference: 11212121 - Bioorg Med Chem Lett. 2001 Feb 12;11(3):403-6
– reference: 9558479 - Annu Rev Physiol. 1998;60:619-42
– reference: 18600388 - J Gastroenterol. 2008;43(6):441-7
– reference: 9507900 - J Ethnopharmacol. 1998 Jan;59(3):167-72
– reference: 10334982 - Science. 1999 May 21;284(5418):1328-33
– reference: 10390246 - Antimicrob Agents Chemother. 1999 Jul;43(7):1788-91
– reference: 17760719 - Helicobacter. 2007 Oct;12(5):510-7
– reference: 17768020 - J Ethnopharmacol. 2007 Oct 8;114(1):72-7
– reference: 22433535 - J Ethnopharmacol. 2012 May 7;141(1):403-10
– reference: 15039755 - Nat Rev Immunol. 2004 Mar;4(3):181-9
– reference: 9797374 - Gastroenterology. 1998 Nov;115(5):1186-96
– reference: 19386474 - Int J Antimicrob Agents. 2009 Jul;34(1):50-9
– reference: 11783701 - Eur J Clin Microbiol Infect Dis. 2001 Nov;20(11):820-3
– reference: 19467317 - J Ethnopharmacol. 2009 Jul 30;124(3):642-5
– reference: 9865693 - Cell. 1998 Dec 11;95(6):749-58
– reference: 21722823 - Arch Med Res. 2011 Apr;42(3):252-7
– reference: 12126754 - Free Radic Biol Med. 2002 Aug 1;33(3):323-36
– reference: 11774979 - Am J Gastroenterol. 2001 Dec;96(12):3454-5
– reference: 11292234 - Phytomedicine. 2001 Jan;8(1):16-23
SSID ssj0023352
Score 2.4675405
SecondaryResourceType review_article
Snippet More than 50%of the world population is infected with Helicobacter pylori(H.pylori).The bacterium highly links to peptic ulcer diseases and duodenal...
More than 50% of the world population is infected with Helicobacter pylori (H. pylori). The bacterium highly links to peptic ulcer diseases and duodenal ulcer,...
More than 50% of the world population is infected with Helicobacter pylori ( H. pylori ). The bacterium highly links to peptic ulcer diseases and duodenal...
SourceID pubmedcentral
proquest
pubmed
crossref
chongqing
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 10368
SubjectTerms Animals
Anti-Bacterial Agents - therapeutic use
Anti-Inflammatory Agents - therapeutic use
factor
Gastritis - diagnosis
Gastritis - drug therapy
Gastritis - microbiology
Helicobacter
Helicobacter Infections - complications
Helicobacter Infections - diagnosis
Helicobacter Infections - drug therapy
Helicobacter Infections - microbiology
Helicobacter pylori - drug effects
Helicobacter pylori - genetics
Helicobacter pylori - metabolism
Helicobacter pylori - pathogenicity
Humans
Medicinal
Phytotherapy
pla
Plant Preparations - therapeutic use
Plants, Medicinal
pylori
Topic Highlight
Treatment Outcome
Virulence
Virulence Factors - genetics
Virulence Factors - metabolism
Title Medicinal plant activity on Helicobacter pylori related diseases
URI http://lib.cqvip.com/qk/84123X/201430/90888889504849525148484954.html
https://www.ncbi.nlm.nih.gov/pubmed/25132753
https://www.proquest.com/docview/1566402697
https://pubmed.ncbi.nlm.nih.gov/PMC4130844
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKcuGCQLzKS0HCF5aUxHYS-0bbTbVCWk67YjlFTuJsi6p0Hy1I_AZ-NDOOE1K6IJaqSi17bLf-pvPwY0zIayFysIMZ9_NIVb7QpvA1qD0_ZlqxvNIBt-Gajj7Ghyfiw2l0Ohj86O1a2qzzUfH92nMl_4Mq5AGueEr2Bsh2jUIGpAFfeALC8PwnjI-ahXE8TLXUuFe8cHdBrDCA1RJAzm0w5v1zdMsXzcEVsDDdqsxV3zKlqaATSVVM04SqiMopTSWVHN-YYHQc2KKEyoimER0f0DEQx1QdYCnkTGZYms7oZErV2Naa0EloaWIqE6wuFZXS0WACGoR-2wZVsEPTTVR83ujan843pt7_pJ2-ddMVocD51-aYqJOwODcKRmOjZY3NYyA2fdCTQY_h3GpNI1ZD0LOyp6Mxqju7TgFgMB1A7duXs9FXFowW3EYVaOtuxdXGDV7wUhHIMPASwc6DT0yJW-Q2A6eDt3M_zn3H02l27dz9gGaNHHt8t9MfRuqYr-qzC7A_ti2eHTfm9924PfPm-B656_wSb9ww2X0yMPUD8r5jMM8ymNcymLeqvT6DeQ2DeY7BvJbBHpKTWXo8PfTdlRt-AcJ87VeKK16JIgwKLvOiBAnNIjBpWclKUA7SRLnCCwpiU5ZxUYJGCGUeizzkVcAqzfkjslevavOEeIHUSV6WFfijWphSS8USZYwqudCqEtWQvO2GKDtvQqtkfwZlSIJ2FLPCha_HW1SWGbixCEIGIGQAQgYgZBaEIXnTVWk7-AvxqxaaDCQsLpvp2qw2VxnOcIiAxSoZkscNVF1z8AWBEyI-JMkWiB0BRm_fLqkXcxvFHa1HKcTTmw3DM3Ln17_qOdlbX27MCzCL1_lLy60_Ady6ndA
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Medicinal+plant+activity+on+Helicobacter+pylori+related+diseases&rft.jtitle=%E4%B8%96%E7%95%8C%E8%83%83%E8%82%A0%E7%97%85%E5%AD%A6%E6%9D%82%E5%BF%97%EF%BC%9A%E8%8B%B1%E6%96%87%E7%89%88%EF%BC%88%E7%94%B5%E5%AD%90%E7%89%88%EF%BC%89&rft.au=Yuan-Chuen+Wang&rft.date=2014-08-14&rft.issn=1007-9327&rft.eissn=2219-2840&rft.issue=30&rft.spage=10368&rft.epage=10382&rft_id=info:doi/10.3748%2Fwjg.v20.i30.10368&rft.externalDocID=90888889504849525148484954
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F84123X%2F84123X.jpg